(1)
Yousefi, B.; Samadi, N.; Baradaran, B.; Rameshknia, V.; Shafiei-Irannejad, V.; Majidinia, M.; Targhaze, N.; Zarghami, N. Differential Effects of Peroxisome Proliferator-Activated Receptor Agonists on Doxorubicin-Resistant Human Myelogenous Leukemia (K562/DOX) Cells. Cell Mol Biol (Noisy-le-grand) 2015, 61, 118-122.